Pharma companies still slow to adopt hybrid sales rep and digital commercial models – surveynews2023-09-28T19:07:07+00:00September 28th, 2023|Endpoints News|
Federal government shutdown watch: FDA and industry prep for likely closure Oct. 1news2023-09-28T18:45:42+00:00September 28th, 2023|Endpoints News|
Takeda wins FDA approval for subcutaneous Entyvio in ulcerative colitisnews2023-09-28T18:39:10+00:00September 28th, 2023|Endpoints News|
PBM reforms: Senate Finance Committee leaders introduce another bipartisan billnews2023-09-28T18:33:17+00:00September 28th, 2023|Endpoints News|
CureVac: Delay in German court over alleged infringement of Covid-19 vaccine by BioNTech a positive signnews2023-09-28T18:05:53+00:00September 28th, 2023|Endpoints News|
J&J Vision looks to the future with new corporate campaign spanning generations of eye healthnews2023-09-28T17:28:26+00:00September 28th, 2023|Endpoints News|
Bionomics’ stock skyrockets 340% after PTSD candidate passes PhIIb testnews2023-09-28T15:34:37+00:00September 28th, 2023|Endpoints News|
FDA approves Amicus Therapeutics’ combo therapy for Pompe diseasenews2023-09-28T15:27:19+00:00September 28th, 2023|Endpoints News|
Kristen Hege recounts an important chapter in CAR-T history — and how that compares to an adventurous coastal thru-hikenews2023-09-28T15:16:31+00:00September 28th, 2023|Endpoints News|
CDER tweaks Ozempic’s post-marketing label to include risk for GI disordernews2023-09-28T15:15:43+00:00September 28th, 2023|Endpoints News|
